A novel cooperative therapeutic regimen using gene fusion neoantigen-specific TCR-engineered T cells mediated sustained preclinical efficacy in solid tumors independent on inherent mutation profiling
Ontology highlight
ABSTRACT: A novel cooperative therapeutic regimen using gene fusion neoantigen-specific TCR-engineered T cells mediated sustained preclinical efficacy in solid tumors independent on inherent mutation profiling
PROVIDER: PRJNA1018872 | ENA |
REPOSITORIES: ENA
ACCESS DATA